GCC Generic Injectables| Market Size, Share and Opportunities Analysis with Forecast to 2023


Posted November 13, 2019 by prachitisharma98

Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use.

 
Bharat Book Bureau Provides the Trending Market Research Report on ‘‘GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

The GCC Generic Injectables Market was worth US$ 392 Million in 2017. The market is further projected to reach a value of US$ 776 Million by 2023, exhibiting a CAGR of 12.1% over the forecast period. Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases, osteoporosis, etc. In the GCC region, a rise in the prevalence of various lifestyle diseases has catalysed the uptake of generic injectables. The lower cost of these drugs compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.

Request a free sample copy of GCC Generic Injectables Market Report @
https://www.bharatbook.com/marketreports/sample/reports/1225894

GCC Generic Injectables Market Drivers/Constraints:

An increase in the emigrant population along with a rise in both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The consequent surge in the overall healthcare costs has boosted the demand for generic injectables.
Upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers.
The total number of manufacturers in the generic injectables market is limited as compared to oral generics. This results in lower price erosion and significantly higher margins.
Some of the other factors driving the generic injectables market in the region include a rising ageing population, development of the private healthcare market, improving standards of living, better awareness of health issues, etc.

Regional Insights:

Region-wise, Saudi Arabia represents the leading market, holding the largest market share. Other major regions include the UAE, Kuwait, Qatar, Oman and Bahrain.

Therapeutic Area Insights:

Based on the therapeutic area, oncology holds the largest market share. A rise in the number of cancer diagnoses coupled with improved access to treatment is currently driving the growth of this segment. Other major segments include anaesthesia, anti-infectives, cardiovascular and parenteral nutrition.

Distribution Channel Insights:

The market has also been divided on the basis of distribution channel as hospitals, clinics and retail pharmacy stores. Generic injectables are majorly distributed through hospitals.

Container Types:

On the basis of container type, the market has been segmented into vials, prefilled syringes, ampoules and premix. Currently, vials represent the major container type, accounting for the majority of the total market share.

Competitive Landscape:

The competitive landscape of the GCC generic injectables market along with the profiles of key players has also been analysed in the report.

This report provides a deep insight into the GCC generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the generic injectables industry in any manner.

Browse our full report with Table of Content :
https://www.bharatbook.com/marketreports/gcc-generic-injectables-market-industry-trends-share-size-growth-opportunity-and-forecast-2018-2023/1225894

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Prachiti Sharma
Phone 27810773
Business Address 808, Real Tech Park, 8th Floor, Sector -
30A, Vashi, Navi Mumbai - 400703, India.
Country India
Categories Medical
Tags gcc generic injectables market , gcc generic injectables market by product , gcc generic injectables market by region , gcc generic injectables market forecast , gcc generic injectables market outlook , gcc generic injectables market report , gcc generic injectables market research report , gcc generic injectables market study
Last Updated November 13, 2019